- Endo International plc (NASDAQ:ENDP) swing trade is acting well and looks to me like it wants to get going. It popped 42 cents, or 9%, to 5.08, with a high of 5.15, on 9 million shares, on Thursday. The angle of ascent tells me that there is a possibility that we may take this stock up to 6 3/4, provided it takes out recent resistance at 5 3/4.
- ImmunoGen , Inc. (NASDAQ:IMGN) swing trade is acting great. It ramped up four days in a row, going from about 3 1/2 to 5 1/2. On Thursday, it gained 51 cents, or 10.26%, to 5.48, with a high of 5.52, and then ramped up to 5.83 in after hours, on 6.8 million shares. There’s some resistance and my target up in 6 zone. I expect it to be tested as early as Friday.
- InMode Ltd . (NASDAQ:INMD) might be coming out of its foreplay. It’s four waves up and in a falling wedge. On Thursday, it jumped 2.33, or 5.5%, to 44.43, and a high of 45.13, on 1.8 million shares, and looks like it’s popping. Volume is coming into it. If it can get out of the 3-day trading range, I think it will see 48, and then something in the low, and then mid, 50’s.
- Oramed Pharmaceuticals Inc . (NASDAQ:ORMP) broke out of a beautiful wedge and I put a swing on it. On Thursday, it popped 39 cents, or 7.29%, to 5.74, reaching a 52-week and session high of 6.05, on 421,077 shares traded. It looks like it’s going to run up to 6 1/2 and then 7 1/2. It has great technicals.
- Rite Aid Corporation (NYSE:RAD), which I knew I was right about when it broke out, then pulled back in an orderly fashion, but way too far for me, and stopped out some of our traders. I still think this stock has re-established a trend with a breakaway move. It ran up 3.52, or 42%, to 11.84, with a high of 12.50, on 37.4 million shares on Thursday. I’m looking for it to run up to 13-13 1/2 as soon as Friday or Monday.
Stocks on the long side included Abeona Therapeutics Inc. (ABEO), Acasti Pharma Inc. (ACST), Conagra Brands, Inc. (CAG), Catalyst Biosciences, Inc. (CBIO), CytomX Therapeutics, Inc. (CTMX), Endo International plc (ENDP), GreenSky, Inc. (GSKY), ImmunoGen, Inc. (IMGN), InMode Ltd. (INMD), Inovio Pharmaceuticals, Inc. (INO), Contango Oil & Gas Company (MCF), Nordic American Tankers Limited (NAT), Oramed Pharmaceuticals Inc. (ORMP), PhaseBio Pharmaceuticals, Inc. (PHAS), PolyOne Corporation (POL), Rite Aid Corporation (RAD), Recro Pharma, Inc. (REPH), Virgin Galactic Holdings, Inc. (SPCE), Stage Stores, Inc. (SSI), Zogenix, Inc. (ZGNX), KLX Energy Services Holdings, Inc. (KLXE), Pfenex Inc. (PFNX), Mallinckrodt (NYSE:MNK) Public Limited Company (MNK), Ferro Corporation (FOE), Clovis Oncology, Inc. (CLVS), TG Therapeutics, Inc. (TGTX), Aurinia Pharmaceuticals Inc. (AUPH), Dynavax Technologies Corporation (DVAX), SeaChange International, Inc. (SEAC), and comScore, Inc. (SCOR).